315 related articles for article (PubMed ID: 20218889)
1. Japanese encephalitis: new options for active immunization.
Halstead SB; Thomas SJ
Clin Infect Dis; 2010 Apr; 50(8):1155-64. PubMed ID: 20218889
[TBL] [Abstract][Full Text] [Related]
2. New Japanese encephalitis vaccines: alternatives to production in mouse brain.
Halstead SB; Thomas SJ
Expert Rev Vaccines; 2011 Mar; 10(3):355-64. PubMed ID: 21434803
[TBL] [Abstract][Full Text] [Related]
3. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
[TBL] [Abstract][Full Text] [Related]
4. Japanese encephalitis: update on vaccines and vaccine recommendations.
Wilder-Smith A; Halstead SB
Curr Opin Infect Dis; 2010 Oct; 23(5):426-31. PubMed ID: 20581670
[TBL] [Abstract][Full Text] [Related]
5. IC51 Japanese encephalitis vaccine.
Kollaritsch H; Paulke-Korinek M; Dubischar-Kastner K
Expert Opin Biol Ther; 2009 Jul; 9(7):921-31. PubMed ID: 19527110
[TBL] [Abstract][Full Text] [Related]
6. IMOJEV(®): a Yellow fever virus-based novel Japanese encephalitis vaccine.
Appaiahgari MB; Vrati S
Expert Rev Vaccines; 2010 Dec; 9(12):1371-84. PubMed ID: 21105774
[TBL] [Abstract][Full Text] [Related]
7. Ixiaro: a new vaccine against Japanese encephalitis.
Jelinek T
Expert Rev Vaccines; 2009 Nov; 8(11):1501-11. PubMed ID: 19863241
[TBL] [Abstract][Full Text] [Related]
8. Japanese encephalitis vaccines: moving away from the mouse brain.
Zanin MP; Webster DE; Martin JL; Wesselingh SL
Expert Rev Vaccines; 2003 Jun; 2(3):407-16. PubMed ID: 12903806
[TBL] [Abstract][Full Text] [Related]
9. Recommendations for use of a booster dose of inactivated vero cell culture-derived Japanese encephalitis vaccine: advisory committee on immunization practices, 2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 May; 60(20):661-3. PubMed ID: 21617632
[TBL] [Abstract][Full Text] [Related]
10. A chimeric live attenuated vaccine against Japanese encephalitis.
Jones T
Expert Rev Vaccines; 2004 Jun; 3(3):243-8. PubMed ID: 15176941
[TBL] [Abstract][Full Text] [Related]
11. New vaccines for Japanese encephalitis.
Halstead SB; Thomas SJ
Curr Infect Dis Rep; 2010 May; 12(3):174-80. PubMed ID: 21308526
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities.
Yu Y
Vaccine; 2010 May; 28(21):3635-41. PubMed ID: 20226891
[TBL] [Abstract][Full Text] [Related]
14. Japanese encephalitis vaccine in travelers.
Jelinek T
Expert Rev Vaccines; 2008 Jul; 7(5):689-93. PubMed ID: 18564023
[TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine.
Tauber E; Kollaritsch H; von Sonnenburg F; Lademann M; Jilma B; Firbas C; Jelinek T; Beckett C; Knobloch J; McBride WJ; Schuller E; Kaltenböck A; Sun W; Lyons A
J Infect Dis; 2008 Aug; 198(4):493-9. PubMed ID: 18588481
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of mouse-brain inactivated Nakayama strain Japanese encephalitis vaccine--results from 30 years experience in Taiwan.
Yang SE; Pan MJ; Tseng HF; Liau MY
Vaccine; 2006 Mar; 24(14):2669-73. PubMed ID: 16314007
[TBL] [Abstract][Full Text] [Related]
17. Update on Japanese encephalitis vaccine for children: United States, May 2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 May; 60(20):664-5. PubMed ID: 21617633
[TBL] [Abstract][Full Text] [Related]
18. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
Zhou B; Jia L; Xu X
Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Feb; 20(1):38-41. PubMed ID: 10682513
[TBL] [Abstract][Full Text] [Related]
19. Current recommendations for the Japanese encephalitis vaccine.
Chen HL; Chang JK; Tang RB
J Chin Med Assoc; 2015 May; 78(5):271-5. PubMed ID: 25841620
[TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of a single administration of live-attenuated Japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-olds: multicenter randomized controlled trial.
Chokephaibulkit K; Sirivichayakul C; Thisyakorn U; Sabchareon A; Pancharoen C; Bouckenooghe A; Gailhardou S; Boaz M; Feroldi E
Pediatr Infect Dis J; 2010 Dec; 29(12):1111-7. PubMed ID: 20856164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
